DANIELLE POTH: Open Payments
NPI 1851024244 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,470 in 248 payments from 19 companies in 2025. Trend: 2023 $742 · 2024 $2,767 · 2025 $5,470
Food & beverage: $5,415Education: $55
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 44 | $1,026 |
| UCB, Inc. | 43 | $1,008 |
| Janssen Biotech, Inc. | 32 | $629 |
| ABBVIE INC. | 40 | $627 |
| Novartis Pharmaceuticals Corporation | 19 | $437 |
| AstraZeneca Pharmaceuticals LP | 10 | $254 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $244 |
| GlaxoSmithKline, LLC. | 10 | $236 |
| Lilly USA, LLC | 12 | $230 |
| Mallinckrodt Hospital Products Inc. | 6 | $175 |
Products named: Bimzelx, TREMFYA, RINVOQ, COSENTYX, ENBREL, OTEZLA, BENLYSTA, TALTZ.
Industry payments across CA — which companies pay providers there.
